Opioid Use Disorder Induces Oxidative Stress and Inflammation: The Attenuating Effect of Methadone Maintenance Treatment
Objective: Frequent use of opioids produces reactive oxygen species, upregulates inflammatory factors, and contributes to opiate dependence. In this study, we examined perturbations of plasma oxidative and inflammatory markers in patients with opioid use disorder in two phases. In the first phase, we compared the oxidative status in patients with opioid use disorders and in healthy controls; and in the second phase, we examined oxidative changes before and after methadone maintenance treatment.
Method: To explore whether oxidative changes were associated with opioid use disorder, we compared plasma oxidative and inflammatory markers in patients with opioid use disorder and in smoking and non-smoking healthy participants. All participants completed measures of catalase (CAT), glutathione (GSH), malondialdehyde (MDA), superoxide dismutase (SOD), matrix metalloproteinase (MMP-9), and TNF-α at baseline. Baseline measures were compared using Kruskal-Wallis test. In the second phase, to explore oxidative changes during transition from opium use to methadone, blood and urine samples of patients with opioid use disorder were re-evaluated on Days 3, 7, and 14 after methadone therapy. Repeated measures analysis was used to determine the relative contribution of intervention to changes in CAT, GSH, MDA, SOD, MMP-9, and TNF-α level over time.
Results: We observed lower SOD and catalase activities, and higher TNF-α and MMP-9 level in patients compared to the two comparison groups. Opioids exacerbated the oxidative imbalance and superimposed the underlying oxidative injury in smoker comparison group. Methadone therapy was associated with lower MMP-9 and TNF-α level, and higher SOD and catalase activities two weeks after therapy; showing an improvement in oxidative profile.
Conclusion: This was an investigation indicating an oxidative imbalance before methadone therapy and during early days of transition from opium use to methadone. Being aware of redox status is crucial for determining an appropriate antioxidant therapy in opioid use disorder.
Monwell B, Bülow P, Gerdner A.Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems? Subst Abuse Treat Prev Policy 2016; 11: 23.
Sharma HS, Sjoquist PO, Ali SF. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51. Curr Pharm Des 2007; 13: 1903-1923.
Gutowicz M, Kazmierczak B, Baranczyk-Kuzma A. The influence of heroin abuse on glutathione-dependent enzymes in human brain. Drug Alcohol Depend 2011; 113: 8-12.
Abdel-Zaher AO, Mostafa MG, Farghaly HS, Hamdy MM, Abdel-Hady RH. Role of oxidative stress and inducible nitric oxide synthase in morphine-induced tolerance and dependence in mice. Effect of alpha-lipoic acid. Behav Brain Res 2013; 247:17-26.
Ghazavi A, Mosayebi G, Solhi H, Rafiei M , Moazzeni SM. Serum markers of inflammation and oxidative stress in chronic opium (Taryak) smokers. Immunol Lett 2013; 153: 22-26.
Xu B, Wang Z, Li G, Li B, Lin H, Zheng R, et al. Heroin-administered mice involved in oxidative stress and exogenous antioxidant-alleviated withdrawal syndrome.Basic Clin Pharmacol Toxicol 2006; 99: 153-161.
Massaad CA, Klann E. Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid Redox Signal 2011; 15; 14: 2013-2054.
Gipson CD, Kupchik YM, Kalivas PW. Rapid, transient synaptic plasticity in addiction. Neuropharmacology 2014; 76 Pt B: 276-286.
Mameli M, Lüscher C. Synaptic plasticity and addiction: learning mechanisms gone awry. Neuropharmacology 2011; 61:1052-1059.
Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis Z S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98: 2572-2579.
Nakamoto K, Kawasaki S, Kobori T, Fujita-Hamabe W, Mizoguchi H, Yamada K, et al. Involvement of matrix metalloproteinase-9 in the development of morphine tolerance. Eur J Pharmacol 2012; 683(1-3): 86-92.
Trivedi MS, Deth R. Redox-based epigenetic status in drug addiction: a potential contributor to gene priming and a mechanistic rationale for metabolic intervention. Front Neurosci 2014; 8: 444.
Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009; 3: CD002209.
Methodology – World Drug Report 2017. https://www.unodc.org/wdr2017/index.html
Gowing LR, Ali RL.The place of detoxification in treatment of opioid dependence. Curr Opin Psychiatry 2006; 19: 266-270.
Koch T, Widera A, Bartzsch K, Schulz S, Brandenburg LO, Wundrack N, et al. Receptor endocytosis counteracts the development of opioid tolerance. Mol Pharmacol 2005; 67: 280-287.
Mannelli P, Patkar A, Rozen S, Matson W, Krishnan R, Kaddurah-Daouk R. Opioid use affects antioxidant activity and purine metabolism: preliminary results. Hum. Psychopharmacol 2009; 24: 666-675.
Koch T, SeifertA, Wu DF, Rankovic M, Kraus J, Börner C, et al. mu-opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2. J Neurochem 2009; 110: 1288-1296.
Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980; 106: 207-212.
Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem 1969; 27: 502-522.
Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD (P) H oxidation. Methods Enzymol 1990; 186: 209-220.
Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-421.
Safarinejad M R, Asgari SA, Farshi A, Ghaedi G, Kolahi AA, Iravani S, et al. The effects of opiate consumption on serum reproductive hormone levels, sperm parameters, seminal plasma antioxidant capacity and sperm DNA integrity. Reprod Toxicol 2013; 36: 18-23.
Miller AF. Superoxide dismutases: ancient enzymes and new insights. FEBS Lett. 2012; 586: 585-595.
Tanriverdi H, Evrengul H, Kuru O, TanriverdiS, Seleci D, Enli Y, et al. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ J 2006; 70: 593-599.
Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34: J258-J265.
Sivaraman SK, Zachariah G, Annamala P. Effect of Smoking on Metalloproteinases (MMPs) Activity in Patients with Acute Myocardial Infarction (AMI). J Clin Diagn Res 2014; 8: 27-30.
Kleber HD. Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci 2007; 9: 455-470.
Ammon-Treiber S, Stolze D, Hollt V. Differential effects of mu-opioid receptor agonists in a hippocampal hypoxia/hypoglycemia model. Brain Res 2007; 1183: 60–65.
Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. Redox regulation of cell survival. Antioxid Redox Signal 2008; 10: 1343–1374.
Carvalho AN, Firuzi O, Gama MJ, van Horssen J, SasoL. Oxidative stress and antioxidants in neurological diseases: is there still hope? Curr Drug Targets. 2017; 18: 705-718.
De Oliveira RB, Gravina FS, Lim R, Brichta AM, Callister RJ, van Helden DF. Heterogeneous responses to antioxidants in noradrenergic neurons of the Locus coeruleus indicate differing susceptibility to free radical content. Oxid Med Cell Longev 2012; 820285.
Zahmatkesh M, Kadkhodaee M, Salarian A, Seifi B, Adeli S. Impact of opioids on oxidative status and related signaling pathways: An integrated view. J Opioid Manag. 2017; 13: 241-251.